Pathway Genomics has agreed to pay $4 million to settle a dispute with the U.S. Department of Justice (DOJ). The genomic testing lab was accused of providing kickbacks to healthcare providers in return for patient referrals. In a statement to reveal the settlement, Pathway said it isn't admitting to any wrongdoing and "may debate some of the merits of the DOJ's allegations." Release | More
> Vijay Pande outlined his vision for Andreessen Horowitz's $200 million bio fund. Q&A
> The NIH committed to generating evidence on mHealth apps by 2020. Article
> Datatrak continued to fightback against activist investors ahead of its upcoming annual meeting. Release
> OmniComm Systems revealed a biopharma company is using its EDC system across its entire pipeline. More
> EnsoData discussed its use of software to speed up the analysis of sleep data. Piece